Evidence map›Paper›PMID 42108359›Full record

ReviewAnnals of surgical oncology2026

The Management of Medullary Thyroid Cancer: A Review.

Amblessed E Onuma, Saba Kurtom, Lauren N Krumeich, Sarah B Fisher, Paxton Dickson, Yinin Hu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amblessed E OnumaCooper University Health Care, Cape May Court House, Camden, NJ, USA.
Saba KurtomUniversity of Washington School of Medicine, Seattle, WA, USA.
Lauren N KrumeichUniversity of Michigan, Ann Arbor, MI, USA.
Sarah B FisherThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Paxton DicksonUniversity of Tennessee Health Science Center, Memphis, TN, USA.
Yinin HuUniversity of Maryland School of Medicine, Baltimore, MD, USA. yinin.hu@som.umaryland.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medullary thyroid cancer (MTC) is a rare neuroendocrine malignancy arising from parafollicular C cells. Diagnosis is based on cytologic and histologic features, supported by biochemical testing for calcitonin and carcinoembryonic antigen, RET germline testing, and appropriate imaging. This educational review, developed by the Society of Surgical Oncology's Endocrine and Head and Neck Disease Site Working Group, provides an updated overview of the diagnosis and management of MTC, emphasizing evolving surgical principles and the integration of targeted therapies. Ongoing multidisciplinary collaboration and participation in clinical trials remain essential to further refine prognostic tools, optimize treatment sequencing, and improve patient outcomes in MTC.

Indexed as

Carcinoma, NeuroendocrineThyroidectomyThyroid NeoplasmsHumansPrognosisMedullary thyroid cancerRETTargeted therapyThyroidectomy

Identifiers

PMID42108359

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.